drugset / Trial / NCT02088957

Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures

NCT02088957

RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to compare the efficacy of Brivaracetam and Phenytoin, both administered intravenously, in adult subjects experiencing nonconvulsive electrographic seizures.

Timeline

Start
2014-03
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Brivaracetam Small molecule 100 mg Intravenous
Comparator Phenytoin Unknown 20 mg/kg Intravenous

Indications